Brain gene injection shows promise for rare childhood disease
NCT ID NCT01801709
First seen Nov 18, 2025 · Last updated May 16, 2026 · Updated 18 times
Summary
This study tested a gene therapy for children with a rare, severe brain disease called metachromatic leukodystrophy (MLD). Five children aged 6 months to 5 years received injections of a harmless virus carrying a working gene directly into their brains. The goal was to see if it was safe and could slow or stop the disease from getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METACHROMATIC LEUKODYSTROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bicêtre Hospital - Paris Sud
Le Kremlin-Bicêtre, France
Conditions
Explore the condition pages connected to this study.